menu
    • menu

    Company profile for Crystalys Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Crystalys is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of gout. Backed by Novo Holdings and Catalys Pacific, our team combines world-class expertise in gout drug development with a mission to deliver safer, more effective therapies. Our lead candidate, Dotinurad, a next-generation URAT1 inhibitor with best-in-class potential, is advancing into global Phase 3 trials as a second-line ther...
    Crystalys is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of gout. Backed by Novo Holdings and Catalys Pacific, our team combines world-class expertise in gout drug development with a mission to deliver safer, more effective therapies. Our lead candidate, Dotinurad, a next-generation URAT1 inhibitor with best-in-class potential, is advancing into global Phase 3 trials as a second-line therapy, supported by extensive clinical data from approvals in multiple Asian markets.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Crystalys TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    12544 High Bluff Dr., #310 San Diego, CA 92130
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://crystalystx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/crystalys-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Crystalys Therapeutics Progresses Dotinurad Phase 3 Trials
    Crystalys Therapeutics Progresses Dotinurad Phase 3 Trials

    21 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/crystalys-therapeutics-advances-phase-3-trials-of-dotinurad-for-the-treatment-of-gout-with-dosing-of-first-patients-302589382.html

    PR NEWSWIRE
    21 Oct 2025
    Share Share
    Fortress, Urica Dose First Patients In Ph3 Dotinurad Gout Trial
    Fortress, Urica Dose First Patients In Ph3 Dotinurad Gout Trial

    21 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/21/3170212/28889/en/Fortress-Biotech-and-Subsidiary-Urica-Therapeutics-Announce-First-Patients-Dosed-in-Crystalys-Therapeutics-Global-Phase-3-Trials-of-Dotinurad-for-the-Treatment-of-Gout.html

    GLOBENEWSWIRE
    21 Oct 2025
    Share Share
    Fortress Biotech And Urica Therapeutics Unveil Crystalys
    Fortress Biotech And Urica Therapeutics Unveil Crystalys

    01 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/01/3159491/28889/en/Fortress-Biotech-and-Subsidiary-Urica-Therapeutics-Announce-Crystalys-Therapeutics-205-Million-Series-A-Financing.html

    GLOBENEWSWIRE
    01 Oct 2025
    Share Share
    Crystalys Launches with $205M Funding for Gout Drug Trials
    Crystalys Launches with $205M Funding for Gout Drug Trials

    30 Sep 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/crystalys-therapeutics-launches-with-205-million-funding-round-trials-gout-drug-2025-09-30/

    REUTERS
    30 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search